Cytosorbents (CTSO) Profit After Tax (QoQ) (2010 - 2026)
Cytosorbents (CTSO) Profit After Tax (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.69% |
| Dec 31, 2025 | -73.41% |
| Sep 30, 2025 | -262.81% |
| Jun 30, 2025 | 231.64% |
| Mar 31, 2025 | 80.45% |
| Dec 31, 2024 | -173.37% |
| Sep 30, 2024 | 35.54% |
| Jun 30, 2024 | 29.48% |
| Mar 31, 2024 | 0.75% |
| Dec 31, 2023 | 33.23% |
| Sep 30, 2023 | -39.19% |
| Jun 30, 2023 | 9.85% |
| Mar 31, 2023 | -855.77% |
| Dec 31, 2022 | 93.72% |
| Sep 30, 2022 | -12.15% |
| Jun 30, 2022 | -21.33% |
| Mar 31, 2022 | 3.66% |
| Dec 31, 2021 | -45.28% |
| Sep 30, 2021 | -36.96% |
| Jun 30, 2021 | -12.23% |